Logical Biological

Executive Summary

Logical Biological is a UK-based supplier of high-quality human biological raw materials, specializing in bulk and custom serum, plasma, tissues, and other biospecimens for the in vitro diagnostics (IVD) control manufacturing and life sciences R&D sectors. Founded in 2018, the company offers both native and engineered disease-state materials to support the development and quality control of diagnostic tests across a wide range of disease areas. By providing essential raw materials for IVD controls, Logical Biological plays a critical role in ensuring the accuracy and reliability of diagnostic tests. The company's focus on quality and customization positions it well to benefit from the growing demand for diagnostic testing and personalized medicine. With no disclosed funding or valuation, Logical Biological operates as a private entity, likely relying on organic growth and customer relationships. Its niche position in the biospecimen supply chain offers steady demand, but scalability may depend on expanding its disease-state portfolio and forging strategic partnerships with major IVD manufacturers.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with Major IVD Manufacturer50% success
• Q2 2026Expansion of Disease-State Biospecimen Portfolio70% success
• TBDSeries A Funding Round30% success